Related Experiment Video
Updated: May 17, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Antineoplastic activity of a nutrient mixture in Y-79 malignant retinoblastoma cells
M Waheed Roomi1, Nusrath Roomi, Bilwa Bhanap
1Dr Rath Research Institute, Cancer Division, Santa Clara, CA 95050, USA.
Abstract:
Retinoblastoma is one of the most common ocular malignancies in children under the age of six. Occasionally, retinoblastoma metastasizes to extraocular organs including the bone, lung and brain. Left untreated, retinoblastoma is fatal. At present, there is no effective treatment for metastatic retinoblastoma. We investigated the antineoplastic activity of a nutrient mixture (NM) (lysine, proline, ascorbic acid and green tea extract) at concentrations of 10, 50, 100, 500 and 1,000 µg/ml in triplicate at each dose in the human malignant retinoblastoma Y-79 cell line. The parameters used were cell proliferation, expression of matrix metalloproteinases (MMPs), invasion through Matrigel, morphology and apoptosis. Cell viability was assessed by trypan blue dye exclusion test. Invasion was evaluated through Matrigel and MMP activity by gelatinase zymography. H&E staining for morphological cell alterations and apoptotic studies using the Live Green Poly Caspase Detection kit were also conducted. The nutrient mixture at 10-100 µg/ml demonstrated approximately 25% toxicity towards Y-79 retinoblastoma cells and significant toxicity at 500 and 1,000 µg/ml. The Y-79 cells secreted only MMP-2 as demonstrated by zymography; the nutrient mixture had no effect on MMP-2 expression up to 100 µg/ml, but completely blocked it at 500 µg/ml. Importantly, Y-79 retinoblastoma cells were not invasive through Matrigel. H&E staining showed cell morphological changes related to apoptosis, which was confirmed using the Live Green Poly Caspase Detection kit. Our results suggest that this nutrient mixture, which inhibited cell proliferation, expression of MMP-2 and induced apoptosis, may be a candidate for further exploration for its therapeutic potential in metastatic retinoblastoma.
Insights
A nutrient mixture containing lysine, proline, ascorbic acid, and green tea extract showed antineoplastic effects against retinoblastoma cells. This mixture inhibited cell proliferation and induced apoptosis, suggesting potential for treating metastatic retinoblastoma.
Area of Science:
- Oncology
- Cell Biology
- Nutritional Science
Background:
- Retinoblastoma is a common childhood eye cancer, with metastatic forms being fatal.
- Current treatments for metastatic retinoblastoma are ineffective.
- Investigating novel therapeutic agents is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the antineoplastic activity of a specific nutrient mixture (NM) in human retinoblastoma Y-79 cells.
- To assess the effects of NM on cell proliferation, matrix metalloproteinase (MMP) expression, invasion, morphology, and apoptosis.
- To determine the therapeutic potential of NM for metastatic retinoblastoma.
Main Methods:
- Y-79 retinoblastoma cells were treated with varying concentrations of the nutrient mixture (lysine, proline, ascorbic acid, green tea extract).
- Assays included cell viability (trypan blue), Matrigel invasion, MMP activity (zymography), morphology (H&E staining), and apoptosis (Live Green Poly Caspase Detection kit).
Main Results:
- The nutrient mixture exhibited dose-dependent toxicity against Y-79 cells, with significant effects at higher concentrations.
- NM inhibited MMP-2 expression at 500 µg/ml and induced morphological changes and apoptosis in Y-79 cells.
- Y-79 cells demonstrated no invasive potential through Matrigel in this study.
Conclusions:
- The nutrient mixture demonstrated significant antineoplastic activity by inhibiting proliferation and inducing apoptosis in retinoblastoma cells.
- NM's ability to inhibit MMP-2 expression warrants further investigation for its role in retinoblastoma metastasis.
- This nutrient mixture shows promise as a potential therapeutic candidate for metastatic retinoblastoma.
